热门资讯> 正文

内部人士购买后，Cabaletta Bio股价攀升

2026-01-22 21:08

Cabaletta Bio(CABA) 0

Cabaletta Bio (CABA) shares climbed 11% on Thursday following recent insider purchases. Michael Gerard, the company’s General Counsel, bought 6,600 shares of Cabaletta Bio (CABA) on January 21, 2026, totaling $14,979.
Chang David J., Chief Medical Officer, purchased 8,800 shares of the company at an average price of $2.26 per share.
Binder Gwendolyn, President of Science & Technology, acquired 11,312 shares at an average price of $2.1891, totaling 31,312 shares owned.

More on Cabaletta Bio

Cabaletta Bio, Inc. (CABA) Presents At Citi Annual Global Healthcare Conference 2025 Transcript
Seeking Alpha’s Quant Rating on Cabaletta Bio
Historical earnings data for Cabaletta Bio
Financial information for Cabaletta Bio

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。